Badgley, Phelps & Bell’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
BG
Badgley, Phelps & Bell's AGN Position: Q1 2018 in Review
Badgley, Phelps & Bell sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 3,087 shares — an estimated $505K sold.
Badgley, Phelps & Bell first reported a position in AGN in Q2 2013 and held it in 19 quarters. The position peaked at $15.4M in Q4 2014. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.
- Badgley, Phelps & Bell reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
- Badgley, Phelps & Bell sold 3,087 Allergan plc shares in Q1 2018, an estimated $505K.
- Badgley, Phelps & Bell first reported a position in Allergan plc in Q2 2013 and held it in 19 quarters.
- Badgley, Phelps & Bell's Allergan plc position peaked at $15.4M in Q4 2014.
- 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.
Based on Badgley, Phelps & Bell's 13F filing for Q1 2018, filed 8 May 2018.